ClearBridge Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $284M | Buy |
|
|||||
|
2025
Q2 | $182M | Buy |
|
|||||
|
2025
Q1 | $2.1M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $15.8M | Buy |
|
|||||
|
2023
Q1 | $15.3M | Buy |
|
|||||
|
2022
Q4 | $13.5M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $54K | Hold |
|
|||||
|
2020
Q1 | $40K | Sell |
|
|||||
|
2019
Q4 | $44K | Hold |
|
|||||
|
2019
Q3 | $30K | Hold |
|
|||||
|
2019
Q2 | $27K | Hold |
|
|||||
|
2019
Q1 | $35K | Hold |
|
|||||
|
2018
Q4 | $27K | Hold |
|
|||||
|
2018
Q3 | $33K | Hold |
|
|||||
|
2018
Q2 | $37K | Sell |
|
|||||
|
2018
Q1 | $253K | Sell |
|
|||||
|
2017
Q4 | $320K | Sell |
|
|||||
|
2017
Q3 | $472K | Sell |
|
|||||
|
2017
Q2 | $338K | Buy |
|
|||||
|
2017
Q1 | $57K | Hold |
|
|||||
|
2016
Q4 | $41K | Buy |
|
|||||
|
2016
Q3 | $74K | Buy |
|
|||||
|
2016
Q2 | $33K | Buy |
|